To study the problems faced by innover from conception idea to filling patent in Indian pharmaceutical industry

被引:1
|
作者
Zambad, Sarika [1 ]
Londhe, B. R. [2 ]
机构
[1] Sinhgad Inst, Pune, Maharashtra, India
[2] Symbiosis Int Univ, Symbiosis Inst Management Studies, Pune, Maharashtra, India
关键词
Amendment; innovation; IPR; Pharma companies;
D O I
10.1016/S2212-5671(14)00247-0
中图分类号
F [经济];
学科分类号
02 ;
摘要
India's pharmaceutical sector is currently undergoing unprecedented change. India ratified the agreement establishing the World Trade Organization (WTO). This Agreement, inter-alia, contains an Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) which lays down minimum standards for protection and enforcement of IPR which are required to promote effective and adequate protection of IPR with a view to reducing distortions. Much of this is due to the country's introduction, on January 1, 2005, of a system of product patents; before that, only patents for processes were permitted to be issued. The purpose of this research paper is to study the problems faced by innover in filling patent in Indian pharmaceutical industry. The paper also includes study of problem related to research and development activities, patent filling process etc. (C) 2014 Elsevier B.V.
引用
收藏
页码:829 / 837
页数:9
相关论文
共 50 条